Our team has been hard at work parsing out the most important trends and generating meaningful insights across our customer segments for your company’s business needs. Here’s a quick overview of all of the reports and insights we’ve released this summer, which you can dive into here after signing into our client portal.
For further insights and musings on the oncology sector, please also check out our latest articles at https://www.hmpmarketaccessinsights.com/insights. From articles on the Enhancing Oncology Model and IDN pharmacy performance metrics to payer pathways, we are sure to cover a topic that piques your interest!
In part 2 of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore the operational realities of oncology practice economics.
Lee BlansettIn part 1 of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore the current state of oncology practice economics.
Lee BlansettAs the Inflation Reduction Act (IRA) introduces new Maximum Fair Pricing (MFP) rules, integrated delivery networks (IDNs) and manufacturers will face the complexities of navigating overlapping 340B discounts and MFPs.
Emma Bijesse